Head-To-Head Comparison: Nemaura Medical (NASDAQ:NMRD) & Biotricity (NASDAQ:BTCY)

Valuation and Earnings

This table compares Nemaura Medical and Biotricity”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nemaura Medical	$3,017.00	2.67	-$14.14 million	($0.50)	0.00
Biotricity	$12.06 million	1.09	-$14.09 million	($0.17)	-2.88

Biotricity has higher revenue and earnings than Nemaura Medical. Biotricity is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Nemaura Medical and Biotricity’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nemaura Medical	N/A	N/A	N/A
Biotricity	-80.42%	N/A	-188.47%

Insider & Institutional Ownership

4.4% of Nemaura Medical shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Nemaura Medical has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

Summary

Nemaura Medical beats Biotricity on 6 of the 10 factors compared between the two stocks.

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.